Development of Drug-Induced Cutaneous Vasculitis in a Patient With Relapsed Angioimmunoblastic T-Cell Lymphoma Treated With Novel Bortezomib and Panobinostat Combination: A Possible Surrogate Marker of Response

Cancer Science & Research: Open Access
doi 10.15226/csroa.2014.00109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Symbiosis Group

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy